MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: Studies in patients with polymyositis, dermatomyositis, and inclusion body myositis

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 12, 1996, Pages 1205-1209

  Schneider, Christiane ^a   Gold, Ralf ^a,d   Dalakas, Marinos C ^b   Schmied, Mascha ^c   Lassmann, Hans ^c   Toyka, Klaus V ^a   Hartung, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Autoinmmune disorders; Fas antigen; Human inflammatory myopathies; MHC class I cytotoxicity; T cell apoptosis

Indexed keywords

FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY; DERMATOMYOSITIS; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MUSCLE ATROPHY; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029914014     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199612000-00003     Document Type: Article

References (28)

1. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992;10: 267-93
2. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306
3. Gold R, Schmied M, Giegerich G, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25
4. Pender MP, Nguyen KB, McCombe PA, Kerr JF. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991;104:81-87
5. Schmied M, Breitschopf H, Gold R, et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993;143:446-52
6. Zettl UK, Gold R, Hartung HP, Toyka KV. Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci Let 1994;176:75-79
7. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117:1311-22
8. Barac-Lates V, Wege H, Lassmann H. Apoptosis of T-lymphocytes in Corona Virus induced encephalomyelitis. Reg Immunol 1996 Forthcoming.
9. Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98
10. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988;23:168-73
11. Nagata S, Golstein P. The Fas death factor. Science 1995;267:1449-55
12. Engel AG. The muscle biopsy. In: Engel AG, Franzini-Armstrong C, eds. Myology, 2nd ed. New York: McGraw-Hill, 1994:822-31
13. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57
14. Gallarod E, Leon-Monzon M, Dalakas MC. Type II muscle fibers express Fas antigen: Implications in the cause of muscle atrophy by apoptosis [abstract]. Neurology 1995;45(4):A236-A237
15. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990;11:847-53
16. ffrench-Constant C. Pathogenesis of multiple sclerosis. The Lancet 1994;343:271-75
17. Osborne BA, Schwartz LM. Essential genes that regulate apoptosis. Trends Cell Biol 1994;4:394-99
18. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-87
19. Orimo S, Koga R, Goto K, et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994;4:219-26
20. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. The αβ T cell receptor repertoire in inclusion body myositis: Diverse patterns of gene expression by muscle-infiltrating lymphocytes. J Autoimmun 1994;7:321-33
21. Mantegazza R, Andreetta F, Bernasconi P, et al. Analysis of T cell receptor repertoire of muscle-infiltrating T-lymphocytes in polymyositis - restricted Vαβ rearrangements may indicate antigen-driven selection. J Clin Invest 1993;91:2880-86
22. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome - part I. Muscle & Nerve 1995;18:137-53
23. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barre syndrome - part II. Muscle & Nerve 1995;18:154-64
24. Utz U, McFarland HF. The role of T cells in multiple sclerosis: Implications for therapies targeting the T cell receptor. J Neuropathol Exp Neurol 1994;53:351-58
25. Critchfield JM, Racke MK, Zuniga Pflucker JC, et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994;263:1139-43
26. Pelfrey CM, Tranquill LR, Boehme SA, McFarland HF, Lenardo MJ. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J Immunol 1995;154:6191-6202
27. Nguyen KB, McCombe PA, Pender MP. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J Autoimmun 1994;7:145-52
28. + T cells. J Exp Med 1995;181:1863-68